TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32852421

Group type: EXPERIMENTAL
Intervention: Benzocaine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lidocaine alone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lidocaine and prilocaine mixture
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 48
Study: 35463794

Group type: EXPERIMENTAL
Intervention: Home-based online supervised exercise program (HOSEP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional health education with a home exercise program booklet
Number of subjects: 100
Study: 32506228

Group type: EXPERIMENTAL
Intervention: 0.1% triamcinolone acetonide dental paste
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: S. salivarius K12 lozenge
Number of subjects: 40

Group type: COMPARATOR
Intervention: S. salivarius ATCC® BAA‐2593™ supernatants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 40
Study: 33417903

Group type: EXPERIMENTAL
Intervention: Randomized two-player linear games with fluctuating payoffs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prisoner's Dilemma with independent payoffs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing mutation rate
Number of subjects: 0
Study: 34514495

Group type: EXPERIMENTAL
Intervention: Free diet and single donor standard faecal transplantation (FT) by colonoscopy on Day 1 and rectal enemas on Days 2 and 14 without dietary conditioning of the donor.
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Faecal transplantation (FT) with dietary pre-conditioning of the donor for 14 days and a UC Exclusion Diet (UCED) for the patients.
Number of subjects: 62

Group type: COMPARATOR
Intervention: UC Exclusion Diet (UCED) alone.
Number of subjects: 62
Study: 32769863

Group type: EXPERIMENTAL
Intervention: Mind-body training (MBT)
Number of subjects: 56
Study: 34966524

Group type: EXPERIMENTAL
Intervention: Brain-computer interface-operated lower limb rehabilitation robot (BCI-LLRR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower limb pedal training (control group)
Number of subjects: 0
Study: 32223340

Group type: EXPERIMENTAL
Intervention: Free 1-month membership to Kansas City's bike share system, B-cycle
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no bike share membership)
Number of subjects: 56
Study: 35859473

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied to one socket after tooth extraction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no PRF applied)
Number of subjects: 30
Study: 34521594

Group type: EXPERIMENTAL
Intervention: Tailored nutrition interventions based on individual nutrition literacy levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored nutrition interventions
Number of subjects: 0
Study: 35333599

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Pembrolizumab-chemotherapy
Number of subjects: 882
Study: 34301983

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 33142490

Group type: EXPERIMENTAL
Intervention: 0.025% AJN extract
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: 0.05% AJN extract
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: 0.1% AJN extract
Number of subjects: 720
Study: 32167402

Group type: EXPERIMENTAL
Intervention: Parent group training tailored to the special needs of foster families
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 81
Study: 34090794

Group type: EXPERIMENTAL
Intervention: DCB angioplasty
Number of subjects: 1009

Group type: COMPARATOR
Intervention: PTA
Number of subjects: 1009
Study: 34292050

Group type: EXPERIMENTAL
Intervention: Stress reappraisal
Number of subjects: 339

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 339
Study: 33795297

Group type: EXPERIMENTAL
Intervention: Weekly teriparatide injections (40 ?g/week)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 80
Study: 36375191

Group type: EXPERIMENTAL
Intervention: Low-Intensity ESWT (0.03 mJ/mm2)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Medium-Intensity ESWT (0.09 mJ/mm2)
Number of subjects: 69
Study: 32961445

Group type: EXPERIMENTAL
Intervention: Durvalumab plus EP
Number of subjects: 521

Group type: COMPARATOR
Intervention: EP
Number of subjects: 521
Study: 34711071

Group type: EXPERIMENTAL
Intervention: Integrated Support (IS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Weekly follow-up meetings
Number of subjects: 48
Study: 33588904

Group type: EXPERIMENTAL
Intervention: TEAS plus lifestyle modification
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lifestyle modification alone
Number of subjects: 60
Study: 35081273

Group type: EXPERIMENTAL
Intervention: CNN-6 for extraction, discrimination, and detection
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: Mask R-CNN for segmentation
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: LeNet-5 for diagnosis and classification
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: Weighted models for diagnosis and classification
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Radiologists' subjective diagnoses
Number of subjects: 1016
Study: 33612170

Group type: EXPERIMENTAL
Intervention: Activity Band PLUS
Number of subjects: 488
Study: 33341925

Group type: COMPARATOR
Intervention: Survey version A (no risk information provided)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Survey version B (risk information provided)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Survey version A and B (comparison)
Number of subjects: 293
Study: 34162330

Group type: EXPERIMENTAL
Intervention: Extension position group (EP group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Neutral position group (NP group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sniffing position group (SP group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 75
Study: 33512387

Group type: EXPERIMENTAL
Intervention: OMT-only group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: OMT + medication group
Number of subjects: 36
Study: 33574872

Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius SGL03
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 35761321

Group type: EXPERIMENTAL
Intervention: STOP intervention (theory-based consultation skills training for pharmacy staff with environmental prompts)
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 1272

Group type: EXPERIMENTAL
Intervention: STOP intervention
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 1272
Study: 32862437

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (3.5 µg/kg followed by 7 µg/kg/h) administered before ischaemia (preconditioning)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (3.5 µg/kg followed by 7 µg/kg/h) administered after beginning ischaemia (post-conditioning)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no dexmedetomidine)
Number of subjects: 18
Study: 34320585

Group type: EXPERIMENTAL
Intervention: New method for anterior boundary demarcation of the nasopharynx
Number of subjects: 20
Study: 34400865

Group type: EXPERIMENTAL
Intervention: Community pharmacy-based medication therapy management programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35945604

Group type: EXPERIMENTAL
Intervention: Zilucoplan
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control
Number of subjects: 81
Study: 34290201

Group type: EXPERIMENTAL
Intervention: Subjective refraction (SR)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Autorefraction (AR)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Wavefront aberrometry (WA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Autorefraction (AR) and Wavefront aberrometry (WA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Partial least squares regression and random forest regression
Number of subjects: 90
Study: 35562420

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation among patients using calcium channel blockers
Number of subjects: 98
Study: 33839443

Group type: EXPERIMENTAL
Intervention: Immediate postoperative D-dimer levels
Number of subjects: 666
Study: 35022728

Group type: EXPERIMENTAL
Intervention: Home-based physical training and activity promotion program (12-week intervention)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Unspecific motor placebo activity (control group)
Number of subjects: 118
Study: 32633662

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Midazolam (0.05 mg/kg)
Number of subjects: 18
Study: 36496466

Group type: EXPERIMENTAL
Intervention: Visual frame (risk visualized)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-visual frame (risk not visualized)
Number of subjects: 0
Study: 33463794

Group type: EXPERIMENTAL
Intervention: 12-week stretching intervention by physical therapists
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (without the intervention)
Number of subjects: 124
Study: 36074457

Group type: EXPERIMENTAL
Intervention: Educational intervention through an informative manual
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine information from the unit (Control)
Number of subjects: 0
Study: 33876600

Group type: EXPERIMENTAL
Intervention: Three Source Capture-Recapture (3S-CRC)
Number of subjects: 958

Group type: EXPERIMENTAL
Intervention: Successive Sampling Population Size Estimates (SS-PSE)
Number of subjects: 958
Study: 36357340

Group type: EXPERIMENTAL
Intervention: Center+home‐based intervention
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Center-based intervention
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control
Number of subjects: 325
Study: 33485895

Group type: EXPERIMENTAL
Intervention: Nelipepimut-S (NPS) plus trastuzumab
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 36479561

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Control (sham stimulus)
Number of subjects: 598
Study: 33761180

Group type: EXPERIMENTAL
Intervention: Exercise programme plus a 16-week food education programme (EXP); n = 18, 15-minute group classes and dual-task strategies during exercise
Number of subjects: 33

Group type: COMPARATOR
Intervention: Supervised exercise programme (CON); n = 15, combined exercise, three sessions per week, 75 minutes per session
Number of subjects: 33
Study: 33746216

Group type: EXPERIMENTAL
Intervention: PUFAs supplementation (1000 mg daily)
Number of subjects: 38
Study: 33493448

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin sodium 25,000 IU in 5 mL, administered every 6 hours for 10 days via nebuliser
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin sodium 25,000 IU in 5 mL
Number of subjects: 256
Study: 34065571

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) for 20 min with intermittent stimulation (4 s WB-EMS/4 s rest, at 85 Hz, 350 μs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No WB-EMS after 4 weeks
Number of subjects: 10
Study: 35112672

Group type: EXPERIMENTAL
Intervention: Olfactory training with omega-3 supplementation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Olfactory training only (control group)
Number of subjects: 58
Study: 34148172

Group type: EXPERIMENTAL
Intervention: Oral Neomycin and Bacitracin (OIVA group)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Intravenous antibiotics (IVA group)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: OIVA with mechanical bowel preparation (MBP)
Number of subjects: 204

Group type: COMPARATOR
Intervention: IVA with mechanical bowel preparation (MBP)
Number of subjects: 204
Study: 35911419

Group type: EXPERIMENTAL
Intervention: Non-fasting
Number of subjects: 109

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 109
Study: 34411060

Group type: EXPERIMENTAL
Intervention: Droperidol (20 ?g/kg)
Number of subjects: 20
Study: 34544265

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 5258

Group type: COMPARATOR
Intervention: Dutasteride
Number of subjects: 5258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5258
Study: 32824480

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis with PreforPro
Number of subjects: 68

Group type: COMPARATOR
Intervention: Bifidobacterium animalis subsp. lactis
Number of subjects: 68
Study: 35971297

Group type: EXPERIMENTAL
Intervention: Opium tincture (OT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 204
Study: 33407773

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) plus needle retention (NR)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Both groups (EA + NR and EA)
Number of subjects: 206
Study: 32427113

Group type: EXPERIMENTAL
Intervention: Highly tailored text message and interactive voice response intervention for 12 weeks
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 135
Study: 34031709

Group type: EXPERIMENTAL
Intervention: Single-bundle (SB) ACL reconstruction
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) ACL reconstruction
Number of subjects: 65
Study: 33735275

Group type: EXPERIMENTAL
Intervention: Group 1 (low frequency) - single incentive for absolute HbA1c reduction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 2 (moderate frequency) - two-part incentive for home testing of glucose and absolute HbA1c reduction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 3 (high frequency) - multiple component incentive for home testing, attendance of weekly telephone education classes and absolute HbA1c reduction
Number of subjects: 60
Study: 34857404

Group type: EXPERIMENTAL
Intervention: VR simulator for K‐wire insertion in the distal radius
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard teaching on cadavers
Number of subjects: 20
Study: 32517513

Group type: EXPERIMENTAL
Intervention: Dialogue-based intervention (8 individual 1-1½ hour sessions during the first six months post-stroke)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Dialogue-based intervention
Number of subjects: 322
Study: 35258025

Group type: EXPERIMENTAL
Intervention: Beach Tennis (BT) session
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nonexercise control session (Con)
Number of subjects: 22
Study: 33160280

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) frequency
Number of subjects: 37392

Group type: EXPERIMENTAL
Intervention: Sports participation
Number of subjects: 37392

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) frequency among children who participated in sports
Number of subjects: 37392
Study: 35233748

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (60 mg) and Boswellic acids (200 mg) twice daily for 14 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 33984293

Group type: EXPERIMENTAL
Intervention: Mayo Clinic Care Transitions (MCCT) program (care management following nursing stay, including a home visit and nursing phone calls)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Mayo Clinic Care Transitions (MCCT) program
Number of subjects: 160
Study: 32804205

Group type: EXPERIMENTAL
Intervention: Erythropoietin 1000 U/kg every 48 hours for 6 doses, followed by 400 U/kg 3 times a week through postmenstrual age of 32 weeks.
Number of subjects: 941

Group type: COMPARATOR
Intervention: Placebo (sham injections).
Number of subjects: 941
Study: 35872394

Group type: EXPERIMENTAL
Intervention: Social networking group moderated by peer leaders with access to a static website offering RA materials
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group with access only to the static website
Number of subjects: 210
Study: 33760261

Group type: EXPERIMENTAL
Intervention: ProTaper Universal for Hand Use (Dentsply Sirona)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HyFlex EDM (Coltene‐Whaledent)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reciproc Blue (VDW)
Number of subjects: 60
Study: 32599033

Group type: EXPERIMENTAL
Intervention: Vaccination trials
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Industry-funded trials
Number of subjects: 278

Group type: COMPARATOR
Intervention: US trials
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Overall consent rate
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Trials with consent rate <70%
Number of subjects: 278
Study: 34518263

Group type: EXPERIMENTAL
Intervention: Micronised purified flavonoid fraction (MPFF, Venixxa) 1000 mg orally for 6 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (similar appearing) for 6 months
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: MPFF
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 32924754

Group type: EXPERIMENTAL
Intervention: Baseline EQ-5D scores
Number of subjects: 13801

Group type: EXPERIMENTAL
Intervention: Baseline VAS scores
Number of subjects: 13801

Group type: EXPERIMENTAL
Intervention: Baseline peripheral artery questionnaire scores
Number of subjects: 13801

Group type: EXPERIMENTAL
Intervention: Improved EQ-5D scores over 12 months
Number of subjects: 13801

Group type: EXPERIMENTAL
Intervention: Improved VAS scores over 12 months
Number of subjects: 13801
Study: 35180850

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis (PD)
Number of subjects: 66
Study: 33765725

Group type: EXPERIMENTAL
Intervention: Autologous skin paste group
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional treatment group
Number of subjects: 18
Study: 35421233

Group type: EXPERIMENTAL
Intervention: RRB (125 g fresh equivalents) daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: RRB + FOS (8g) daily
Number of subjects: 26
Study: 34918028

Group type: EXPERIMENTAL
Intervention: EFV1 (efavirenz with TB treatment containing rifapentine 1200mg, isoniazid, pyrazinamide, and either ethambutol or moxifloxacin)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: EFV2 (newly initiating efavirenz with TB treatment containing rifapentine 1200mg, isoniazid, pyrazinamide, and either ethambutol or moxifloxacin)
Number of subjects: 111
Study: 36474181

Group type: EXPERIMENTAL
Intervention: Structured supervised exercise training (EXE)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Motivational counselling on PA (MOT)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 220
Study: 33930612

Group type: EXPERIMENTAL
Intervention: Probiotics + Fish Oil (FO)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Fish Oil + Placebo
Number of subjects: 439

Group type: COMPARATOR
Intervention: Probiotics + Placebo
Number of subjects: 439
Study: 32767506

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei TH14 (105 cfu/kg FM) + cellulase (10,000 unit/kg FM) + molasses (50 g/kg FM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cellulase (10,000 unit/kg FM) + molasses (50 g/kg FM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei TH14 (105 cfu/kg FM) + cellulase (10,000 unit/kg FM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei TH14 (105 cfu/kg FM) + molasses (50 g/kg FM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (untreated rice straw)
Number of subjects: 0
Study: 33221363

Group type: EXPERIMENTAL
Intervention: Expedited transport to a hospital for potential ECPR
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 400
Study: 36036095

Group type: EXPERIMENTAL
Intervention: Clustered missed doses
Number of subjects: 3724

Group type: COMPARATOR
Intervention: No treatment days missed
Number of subjects: 3724
Study: 34137446

Group type: EXPERIMENTAL
Intervention: Fibrin sealant patch
Number of subjects: 247

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Meta-analysis of fibrin patch
Number of subjects: 247

Group type: COMPARATOR
Intervention: Meta-analysis of control
Number of subjects: 247
Study: 32438267

Group type: EXPERIMENTAL
Intervention: 12-week, home-based, physiotherapist-guided exercise program
Number of subjects: 41

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 41
Study: 36849935

Group type: EXPERIMENTAL
Intervention: Dorsal thermoplastic orthosis in a neutral position
Number of subjects: 32

Group type: COMPARATOR
Intervention: Buddy loops
Number of subjects: 32
Study: 33355909

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus paclitaxel
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 140
Study: 32456979

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 20
Study: 35799553

Group type: EXPERIMENTAL
Intervention: Triidothyronine 1 mic/kg 10 doses 8th hourly given orally postoperatively
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (sugar sachets)
Number of subjects: 88
Study: 33635908

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) approach using a genetic risk score (GRS) based on 14 AAM-associated single nucleotide polymorphisms (SNPs)
Number of subjects: 4093

Group type: EXPERIMENTAL
Intervention: Generation-standardized AAM (gsAAM)
Number of subjects: 4093

Group type: EXPERIMENTAL
Intervention: Two-stage least squares (2SLS) approach employing a univariate GRS
Number of subjects: 4093

Group type: EXPERIMENTAL
Intervention: MR diagnostics
Number of subjects: 4093
Study: 32321387

Group type: EXPERIMENTAL
Intervention: Behavioral and educational group intervention
Number of subjects: 35
Study: 35946332

Group type: EXPERIMENTAL
Intervention: Sustained-release morphine and subcutaneous morphine (rapid titration)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Subcutaneous morphine (control)
Number of subjects: 108